Hormone Receptor Positive Breast Cancer in Young Women: A Review

Area of Science:

• Oncology
• Breast Cancer Research
• Endocrinology

Background:

• Global incidence of hormone receptor-positive breast cancer (HR+ BC) is rising in young women.
• HR+ BC in young women is a distinct clinical entity with unique characteristics, outcomes, and treatment responses compared to older women.
• Early-onset HR+ BC poses challenges including fertility concerns, treatment toxicity, and surgical considerations.

Purpose of the Study:

• To review and synthesize existing literature on HR+ breast cancer in young women.
• To highlight the distinct nature of HR+ BC in this demographic.
• To address the paucity of contemporary data on young women with HR+ BC.

Main Methods:

• Literature review of existing studies.
• Synthesis of data on clinicopathological characteristics.
• Analysis of treatment responses and outcomes.

Main Results:

• HR+ BC in young women exhibits distinct clinicopathological features.
• Younger patients with HR+ BC generally face poorer prognoses.
• Treatment responses and outcomes differ significantly from older populations.

Conclusions:

• HR+ BC in young women requires specific clinical attention due to its unique presentation and prognosis.
• Further research is needed to understand the rising incidence and optimize management strategies.
• Addressing fertility and treatment toxicity is crucial for this patient group.